Why Curaleaf Stock Wafted Almost 10% Higher Today There was good news about one of its less-popular products.
President Trump Is Considering Rescheduling Cannabis. Is Now the Time to Load Up on Pot Stocks? If cannabis is no longer a Schedule I drug, that could result in significant tax savings for many marijuana producers.
Why Curaleaf Stock Was Tumbling on Tuesday A group of federal advisors seem to be focused on the negative effects of cannabis.
Why Curaleaf Stock Rocked the Market Today Investors were cheered about movement on the legalization front.
Cannabis ETFs Light Up As Trump Eyes Marijuana Reclassification Cannabis stocks and ETFs skyrocketed after Trump hinted at reclassifying marijuana. Tilray surged 35% in 2 days. Other top performers included Trulieve, Tilray, Curaleaf, and Canopy Growth. This shift could ease federal regulations and improve the industry's growth potential.
Why Curaleaf Stock Is Crushing It Today The momentum from this cannabis company's Q2 update continues.
Why Investors Were so High on Curaleaf Stock Thursday They found quite a bit to like in the marijuana company's latest quarterly earnings release.
Why Curaleaf Stock Popped by 15% on Monday It had a double-digit day in the run-up to its Wednesday quarterly earnings release.
Why Curaleaf Stock Bumped Higher Today Pro-cannabis law reform advocates are continuing to occupy positions of power in U.S. politics.
Why Curaleaf Stock Surged 13% Higher Today A group of top legal officials from around the U.S. made a formal push for marijuana banking reform.
Why Curaleaf Stock Is Smoking Hot Today Curaleaf is a rarity in the marijuana world: A free cash flow-generating cannabis stock.
